NORTHERN TRUST CORP - MYRIAD GENETICS INC ownership

MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 192 filers reported holding MYRIAD GENETICS INC in Q3 2022. The put-call ratio across all filers is 0.37 and the average weighting 0.1%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of MYRIAD GENETICS INC
ValueSharesWeighting
Q3 2023$16,395,111
-30.7%
1,022,139
+0.2%
0.00%
-40.0%
Q2 2023$23,641,305
+2.1%
1,019,901
+2.3%
0.01%0.0%
Q1 2023$23,164,840
+58.2%
997,195
-1.2%
0.01%
+66.7%
Q4 2022$14,645,755
-36.2%
1,009,356
-16.2%
0.00%
-40.0%
Q3 2022$22,969,000
+2.3%
1,203,781
-2.6%
0.01%0.0%
Q2 2022$22,463,000
-28.3%
1,236,245
-0.6%
0.01%
-16.7%
Q1 2022$31,340,000
-11.6%
1,243,663
-3.2%
0.01%0.0%
Q4 2021$35,461,000
-14.6%
1,284,822
-0.1%
0.01%
-14.3%
Q3 2021$41,520,000
+3.0%
1,285,843
-2.5%
0.01%0.0%
Q2 2021$40,317,000
+4.8%
1,318,425
+4.3%
0.01%0.0%
Q1 2021$38,474,000
+13.6%
1,263,491
-26.2%
0.01%0.0%
Q4 2020$33,857,000
+39.5%
1,712,116
-8.0%
0.01%
+40.0%
Q3 2020$24,266,000
+11.3%
1,860,855
-3.3%
0.01%0.0%
Q2 2020$21,812,000
-19.4%
1,923,384
+1.8%
0.01%
-37.5%
Q1 2020$27,046,000
-47.2%
1,890,036
+0.5%
0.01%
-27.3%
Q4 2019$51,224,000
-5.7%
1,881,132
-0.8%
0.01%
-15.4%
Q3 2019$54,307,000
+8.9%
1,896,815
+5.6%
0.01%
+8.3%
Q2 2019$49,879,000
-11.2%
1,795,468
+6.1%
0.01%
-14.3%
Q1 2019$56,171,000
+14.2%
1,691,878
-0.0%
0.01%0.0%
Q4 2018$49,189,000
-35.5%
1,692,079
+2.1%
0.01%
-26.3%
Q3 2018$76,269,000
+13.3%
1,658,013
-8.0%
0.02%
+11.8%
Q2 2018$67,337,000
+29.9%
1,801,882
+2.7%
0.02%
+30.8%
Q1 2018$51,827,000
-8.6%
1,753,888
+6.2%
0.01%
-7.1%
Q4 2017$56,703,000
+2.2%
1,650,968
+7.7%
0.01%0.0%
Q3 2017$55,465,000
+66.1%
1,533,034
+18.6%
0.01%
+55.6%
Q2 2017$33,400,000
+76.4%
1,292,588
+31.1%
0.01%
+80.0%
Q1 2017$18,937,000
+15.2%
986,312
+0.0%
0.01%0.0%
Q4 2016$16,439,000
-21.6%
986,163
-3.2%
0.01%
-28.6%
Q3 2016$20,973,000
-33.2%
1,019,141
-0.6%
0.01%
-30.0%
Q2 2016$31,379,000
-19.3%
1,025,504
-1.3%
0.01%
-23.1%
Q1 2016$38,895,000
-12.2%
1,039,033
+1.3%
0.01%
-13.3%
Q4 2015$44,285,000
+18.1%
1,026,064
+2.6%
0.02%
+15.4%
Q3 2015$37,487,000
+113.2%
1,000,173
+93.4%
0.01%
+160.0%
Q2 2015$17,580,000
+15.9%
517,214
+20.7%
0.01%0.0%
Q1 2015$15,168,000
+5.5%
428,463
+1.5%
0.01%
+25.0%
Q4 2014$14,383,000
-13.4%
422,312
-1.9%
0.00%
-20.0%
Q3 2014$16,612,000
+8.4%
430,686
+9.4%
0.01%0.0%
Q2 2014$15,330,000
-3.3%
393,853
-15.1%
0.01%0.0%
Q1 2014$15,857,000
+83.8%
463,804
+12.8%
0.01%
+66.7%
Q4 2013$8,628,000
-1.3%
411,231
+10.6%
0.00%0.0%
Q3 2013$8,740,000
-9.3%
371,872
+3.7%
0.00%0.0%
Q2 2013$9,636,000358,5770.00%
Other shareholders
MYRIAD GENETICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
SCOPIA CAPITAL MANAGEMENT LP 6,459,139$278,776,0005.53%
Tieton Capital Management, LLC 119,290$5,149,0004.04%
RPg Family Wealth Advisory, LLC 97,202$4,195,238,0003.85%
RK Capital 384,900$16,612,0002.90%
Contrarius Investment Management Ltd 652,288$28,153,0002.65%
S&T BANK/PA 331,885$14,324,0002.22%
Euclidean Technologies Management, LLC 40,917$1,766,0001.90%
AIMZ Investment Advisors, LLC 45,635$1,970,0001.80%
Taylor Frigon Capital Management LLC 34,783$1,486,0001.67%
KILLEN GROUP INC 366,305$15,810,0001.63%
View complete list of MYRIAD GENETICS INC shareholders